UK, January 8, 2020 (OPEN ACCESS GOVERNMENT)- Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies The use of cannabinoids from Cannabis sativa L. in therapeutics involves various routes and forms of administration such as raw herbal …
Read More »
Canada, January 6, 2020 (420 INTEL)- As we enter a new year and a new decade, it’s exciting to predict where the cannabis industry will be in another ten years, and also to reflect on how far the industry as come. The legal industry has made incredible strides over the course …
Read More »
London, December 21, 2109 (INDEPENDET)- Thousands of people with severe epilepsy will be able to access a cannabis-based treatment on the NHS from the new year, it has been revealed. Epidyolex, a cannabidiol (CBD) oral medication, has been fast-tracked by the health service in England to be available from 6 January. Hundreds of children will be among …
Read More »
A $1.4 trillion federal spending bill that passed both houses of Congress and was expected to be signed Friday by President Donald Trump reportedly includes provisions that would benefit hemp and CBD businesses. The Consolidated Appropriations Act of 2020 secures nearly $20 million in funding for the growing hemp industry, according to …
Read More »
London, January 5, 2020 (INDEPENDENT)-Thailand has opened its first full-time cannabis clinics, which will offer traditional remedies based on the drug. The two new centres in Bangkok will also offer alternative cannabis-based medicine, which has been legal in the country since 2018. Hundreds of people – including many cancer patients – received free oil at a new flagship clinic …
Read More »
Donal Carroll Appointed Chief Financial Officer, Dr. Sandra Lottes as Vice President and Head of Clinical Research at BioSciences Division, and Shahzad Shah as Chief Operating Officer at FV Pharma – TORONTO, Jan. 2, 2020 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced the appointments of three key …
Read More »
U.S., January 1, 2019 (420 INTEL)- The World Health Organization estimates that 1 in 13 people on earth suffer from anxiety. Anxiety can manifest itself in various forms, with social anxiety being one of the most common forms. Social anxiety can be an extremely debilitating condition for patients that suffer from it. …
Read More »
U.S, December 28, 2019 (THE MOTLEY FOOL)- Coming off a year where we witnessed more than a dozen cannabis firsts, the expectation had been that a number of marijuana milestones would again be reached in 2019 — and that prediction did prove accurate. Unfortunately, the industry pushing toward profitability was not …
Read More »
TORONTO (December 16, 2019) – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares (the “Shares”) listed on the Nasdaq Capital Market (“Nasdaq”). FSD Pharma expects the Shares to commence trading …
Read More »
TORONTO (December 13, 2019) – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) announces that Raza Bokhari, MD, Executive Co-Chairman and Chief Executive Officer, will present an overview of the Company at the Investor Summit conference at 2:35 p.m. ET on Tuesday, December 17, 2019 …
Read More »Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!
Investment value finders Investment value finders